Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.07 |
mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.068 | 0.07 |
mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.059 | 0.07 |
mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.062 | 0.07 |
mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.065 | 0.07 |
mRNA | pitstop2 | CTRPv2 | pan-cancer | AAC | 0.081 | 0.07 |
mRNA | selumetinib:GDC-0941 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.063 | 0.07 |